» copaxone

• Multiple sclerosis treatment considered for Rett Syndrome

  Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone – as marketed by Teva Pharmaceuticals) is an immunomodulator drug currently used to treat multiple sclerosis and is hypothesized to have some possible affect on patients with Rett Syndrome. It was published on October 14th on PubMed by Ben-Zeev B, Aharoni R, Nissenkorn A, Arnon R. that by raising the Brain derived neurotrophic...

  More..